Bio-Rad Laboratories, Inc. (BIO)
353.70
-11.12
(-3.05%)
USD |
NYSE |
Oct 16, 16:00
353.91
+0.21
(+0.06%)
After-Hours: 20:00
Bio-Rad Laboratories Cash from Investing (Quarterly) : -66.70M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -66.70M |
| March 31, 2026 | -93.20M |
| December 31, 2025 | -34.20M |
| September 30, 2025 | -43.00M |
| June 30, 2025 | -115.40M |
| March 31, 2025 | 2.90M |
| December 31, 2024 | -30.54M |
| September 30, 2024 | -55.64M |
| June 30, 2024 | -30.93M |
| March 31, 2024 | -43.09M |
| December 31, 2023 | 72.20M |
| September 30, 2023 | -9.50M |
| June 30, 2023 | 27.98M |
| March 31, 2023 | -70.47M |
| December 31, 2022 | -58.55M |
| September 30, 2022 | -88.42M |
| June 30, 2022 | -144.48M |
| March 31, 2022 | -916.14M |
| December 31, 2021 | -567.43M |
| September 30, 2021 | -81.35M |
| June 30, 2021 | -100.28M |
| March 31, 2021 | -48.33M |
| December 31, 2020 | -50.11M |
| September 30, 2020 | 90.85M |
| June 30, 2020 | -88.57M |
| Date | Value |
|---|---|
| March 31, 2020 | -12.42M |
| December 31, 2019 | -61.20M |
| September 30, 2019 | -109.91M |
| June 30, 2019 | -15.07M |
| March 31, 2019 | -22.71M |
| December 31, 2018 | -54.81M |
| September 30, 2018 | -29.51M |
| June 30, 2018 | -83.84M |
| March 31, 2018 | -18.82M |
| December 31, 2017 | -13.08M |
| September 30, 2017 | -14.81M |
| June 30, 2017 | -37.28M |
| March 31, 2017 | -110.39M |
| December 31, 2016 | -49.77M |
| September 30, 2016 | -53.43M |
| June 30, 2016 | -59.47M |
| March 31, 2016 | -50.86M |
| December 31, 2015 | -79.57M |
| September 30, 2015 | -27.24M |
| June 30, 2015 | -27.86M |
| March 31, 2015 | -27.99M |
| December 31, 2014 | -49.44M |
| September 30, 2014 | -39.13M |
| June 30, 2014 | -63.02M |
| March 31, 2014 | -38.92M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 164.00M |
| Danaher Corp. | -10.15B |
| Agilent Technologies, Inc. | -1.032B |
| Illumina, Inc. | -122.00M |
| Revvity, Inc. | -3.505M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 98.70M |
| Cash from Financing (Quarterly) | -27.60M |
| Free Cash Flow | 353.10M |
| Free Cash Flow Per Share (Quarterly) | 2.488 |
| Free Cash Flow to Equity (Quarterly) | 74.50M |
| Free Cash Flow to Firm (Quarterly) | 74.99M |
| Free Cash Flow Yield | 3.71% |